Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.' s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2

Korakianiti Evdokia

首页> 外文期刊>European urology >Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.' s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2

【24h】

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.' s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2

机译：回复乔·奥沙里凡，达尼尔海因里奇，尼古拉斯D.詹姆斯等。致编辑的信Re：欧洲药物局的案件对镭r镭-223的改变，用于治疗转移性阉割的前列腺癌。 2019年欧元尿牛; 75：E51-2

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第3期|共1页
作者
Korakianiti Evdokia;
展开▼
作者单位

European Med Agcy 3 Churchill Pl London E14 5EU England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.' s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2 [J] . Korakianiti Evdokia European urology . 2019,第3期

机译：回复乔·奥沙里凡，达尼尔海因里奇，尼古拉斯D.詹姆斯等。致编辑的信Re：欧洲药物局的案件对镭r镭-223的改变，用于治疗转移性阉割的前列腺癌。 2019年欧元尿牛; 75：E51-2
2. Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28 [J] . Moschini Marco, Zaffuto Emanuele, Mattei Agostino, European urology . 2019,第4期

机译：答复尼古拉斯G. Zaorsky，Daniel E. Spratt，以及Pierre Blanchard的信Re：Marco Moschini，Emanuele Zaffuto，Pierre I. Karakiewicz，等。与前列腺癌影响的患者相比，外部光束放射疗法增加了膀胱癌的风险：基于人群的分析。 2019年EUR UROL; 75：319-28
3. Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035. Corticosteroid-associated Adverse Events in Elderly Patients [J] . Fizazi Karim, De Porre Peter, Londhe Anil, European urology . 2016,第2期

机译：回复Giandomenico Roviello，Alberto Bottini和Daniele Generali给编辑的信，关于：Karim Fizazi，Kim N. Chi，Johann S. de Bono等。转移性去势抵抗性前列腺癌患者长期服用低剂量泼尼松和醋酸阿比特龙后，皮质类固醇相关不良事件发生率低。 Eur Urol。在新闻。 http://dx.doi.org/10.1016/j.eururo.2016.02.035。老年患者皮质类固醇相关不良事件
4. Reply to Milan Hora's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861–7 [O] . Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, 2019

机译：回复米兰·霍拉给编辑的信Re：Philip S. Macklin，Mark E. Sullivan，Charles R. Tappe等。经皮肾肿瘤活检的肿瘤播种：关于英国第三节推荐中心的7例报告。 2019年欧洲尿牛; 75：861-7

Reply to Joe O'Sullivan, Daniel Heinrich, Nicholas D. James, et al.' s Letter to the Editor re: The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:e51-2

著录项

相似文献

相关主题

期刊订阅